OP
JAZZ icon

ORG Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

ORG Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.31K Buy
+43
New +$6.59K ﹤0.01% 1100

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ORG Partners's JAZZ Position: Q4 2025 in Review

ORG Partners opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2025: 43 shares worth $7.31K. The stake represents ﹤0.01% of the portfolio and ranks #1100 among its holdings.

573 funds tracked by Wall St. Rank hold JAZZ as of Q4 2025.

  • ORG Partners held 43 shares of Jazz Pharmaceuticals worth $7.31K as of Q4 2025.
  • Jazz Pharmaceuticals was a new ORG Partners position in Q4 2025.
  • Jazz Pharmaceuticals made up ﹤0.01% of ORG Partners's portfolio in Q4 2025, its #1100 holding.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.